Robert T Dell'Orco

Title: The Innovations of Robert T Dell'Orco

Introduction

Robert T Dell'Orco is a notable inventor based in Derwood, MD (US). He has made significant contributions to the field of cancer research, holding a total of 3 patents. His work focuses on the genetic factors influencing cancer susceptibility, which has important implications for diagnostics and treatment.

Latest Patents

Dell'Orco's latest patents include groundbreaking research on the 3' untranslated region (UTR) of the human prohibitin gene. This region has been isolated for use in a cancer susceptibility screen and as a therapeutic agent for cancer treatment. Another significant patent is a diagnostic assay for cancer susceptibility, which determines the lifetime probability of an individual developing cancer based on an allelic variation found in the 3' UTR of the prohibitin gene. The probability is influenced by the sequence at position 729, where the presence of thymine (T) or cytosine (C) can be analyzed using standard techniques, preferably through PCR amplification followed by RFLP analysis.

Career Highlights

Dell'Orco is affiliated with the Oklahoma Medical Research Foundation, where he continues to advance his research in cancer genetics. His work has the potential to change the landscape of cancer diagnostics and treatment, providing valuable insights into genetic predispositions.

Collaborations

He has collaborated with esteemed colleagues such as Eldon R Jupe and Regina Resta, contributing to a rich environment of innovation and research.

Conclusion

Robert T Dell'Orco's contributions to cancer research through his patents and collaborations highlight the importance of genetic understanding in the fight against cancer. His work continues to pave the way for advancements in diagnostic and therapeutic strategies.